ReWalk Robotics (NSDQ:RWLK) said yesterday that it raised $11 million in a warrants offering. Israel-based ReWalk Robotics sold roughly 1.5 million five-year warrants in November 2018 that are now being redeemed for $7.50 apiece, resulting in gross proceeds of $11 million and net proceeds of about $10 million. The warrants were issued on June 5-6, according […]
ReWalk Robotics wins FDA nod for ReStore soft exo-suit
ReWalk Robotics (NSDQ:RWLK) said yesterday that it won FDA 510(k) clearance for its ReStore soft exo-suit system intended for rehabilitation therapy. The Marlborough, Mass.-based company touted the clearance as being the first by the FDA for a soft exo-suit system intended for use in treating stroke survivors with mobility challenges. The ReStore exo-suit features a soft, garment-like […]
ReWalk Robotics wins CE Mark for ReStore soft exo-suit
ReWalk Robotics (NSDQ:RWLK) said today that it won CE Mark clearance in the European Union for its ReStore soft exo-suit designed for use in stroke rehabilitation. The Marlborough, Mass.-based company touted the clearance as the first for a soft exo-suit in the region. The ReStore exo-suit features a soft, garment-like design and is intended to adaptively synchronize […]
ReWalk Robotics raises $4m
ReWalk Robotics (NSDQ:RWLK) has raised approximately $4.3 million in a new round of financing, according to recently posted SEC filings. In the offering, ReWalk Robotics sold warrants to purchase ordinary shares at a purchase price of approximately $5.20, according to the filing. Warrants offered in the round have an exercise price of $5.14 and are exercisable […]
ReWalk Robotics files for exoskeleton suit clearance
ReWalk Robotics (NSDQ:RWLK) said it has applied to FDA for 510(k) clearance of its ReStore exoskeleton suit for gait training during stroke rehabilitation. The Yokneam, Israel-based company designed its exo-suit to provide coordinated plantarflexion and dorsiflexion assistance to a patient’s foot and ankle. It recently won insurer reimbursement from Cigna and completed a clinical trial […]
ReWalk Robotics touts first U.S. insurer reimbursement win for exoskeleton devices
ReWalk Robotics (NSDQ:RWLK) said today that health insurer Cigna will now review submissions for the use of exoskeleton devices for individuals with spinal cord injuries after a change to its coverage policies. The Yokneam, Israel-based company touted the shift as the first of its kind by a major private insurer in the U.S. The policy change […]
ReWalk Robotics shares fall on Q4, 2018 sales miss
Shares in ReWalk Robotics (NSDQ:RWLK) fell today after the rehabilitation exoskeleton maker posted fourth quarter and full year 2018 earnings that beat loss-per-share expectations but missed wide on sales consensus from Wall Street analysts. The Yokneam, Israel-based company posted losses of approximately $5 million, or 10¢ per share, on sales of approximately $1.6 million for the […]
ReWalk Robotics dips on Q3 prelims, registers $15m offering
ReWalk Robotics (NSDQ:RWLK) shares took a hit today after the rehabilitation exoskeleton maker posted preliminary third-quarter sales that missed the mark on Wall Street, even as the company revealed plans for a $15 million public offering. The Yokneam, Israel-based company also registered a $14.8 million offering of stock and other securities. ReWalk said it expects […]
Motus GI taps Moran as CEO | Personnel Moves – September 25, 2018
Motus GI said today that it named Timothy Moran as its new chief executive officer, effective October 1, replacing former CEO Mark Pomeranz who will assume the role of president and COO. Moran has previously served ConvaTec‘s (LON:CTEC) Americas president and helped lead the company through its initial public offering in 2016. Prior to ConvaTec, Moran spent […]
ReWalk Robotics dives on missed Q2 prelims
ReWalk Robotics (NSDQ:RWLK) missed the consensus with its preliminary second-quarter revenues and revealed a financing delay, sending its share price down more than 25% today. Yokneam Ilit, Israel-based ReWalk said it expects to post sales of $1.8 million for the three months ended June 30, which would come in under the $2.0 million expectation on […]
ReWalk Robotics amends soft exoskeleton research, licensing deal with Harvard
UPDATE: Corrected to reflect that ReWalk Robotics was amending an earlier deal. ReWalk Robotics (NSDQ:RWLK) has inked a set of amendments to its collaborative research and exclusive licensing agreement with Harvard Collage related to the development of its soft-suit exoskeleton, according to a recently posted SEC filing. Through the original collaborative deal, both groups will join […]
- 1
- 2
- 3
- 4
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube